ChiCTR2000029569 | Safety and efficacy of umbilical cord blood mononuclear cells conditioned medium in the treatment of severe and critically novel coronavirus pneumonia (COVID-19): a randomized controlled trial | Not Recruiting | 18 | - |
ChiCTR2000030138 | Clinical Trial for Human Mesenchymal Stem Cells in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19) | Not Recruiting | 16 | 75 |
ChiCTR2000029990 | Clinical trials of mesenchymal stem cells for the treatment of pneumonitis caused by novel coronavirus pneumonia (COVID-19) | Recruiting | 18 | 95 |
ChiCTR2000030300 | Umbilical cord mesenchymal stem cells (hucMSCs) in the treatment of high-risk novel coronavirus pneumonia (COVID-19) patients | Recruiting | 18 | 75 |
ChiCTR2000031494 | Clinical study for stem cells in the treatment of severe novel coronavirus pneumonia (COVID-19) | Recruiting | 18 | 90 |
ChiCTR2000031430 | Clinical study of human umbilical cord mesenchymal stem cells in the treatment of novel coronavirus pneumonia (COVID-19) induced pulmonary fibrosis | Recruiting | 18 | 80 |
NCT04252118 | Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19 | Recruiting | 18 | 70 |
NCT04276987 | A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia | Not yet Recruiting | 18 | 75 |
NCT04313322 | Treatment of COVID-19 Patients Using Wharton’s Jelly-Mesenchymal Stem Cells | Recruiting | 18 | - |
NCT04315987 | NestCell® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia (HOPE) | Not yet Recruiting | 18 | - |
NCT04331613 | Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS | Recruiting | 18 | 70 |
NCT04339660 | Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia | Recruiting | 18 | 75 |
NCT04336254 | Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients | Recruiting | 18 | 65 |
NCT04288102 | Treatment With Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19) | Recruiting | 18 | 75 |
NCT04302519 | Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells | Not yet Recruiting | 18 | 75 |
NCT04269525 | Umbilical Cord (UC)-Derived Mesenchymal Stem Cells (MSCs) Treatment for the 2019-novel Coronavirus (nCOV) Pneumonia | Recruiting | 18 | 75 |